Aurora Cannabis (TSE:ACB) Trading Down 2.3%

Aurora Cannabis Inc. (TSE:ACBGet Free Report) shares dropped 2.3% on Monday . The stock traded as low as C$7.53 and last traded at C$7.59. Approximately 288,000 shares traded hands during trading, a decline of 75% from the average daily volume of 1,167,315 shares. The stock had previously closed at C$7.77.

Wall Street Analyst Weigh In

Separately, ATB Capital decreased their price objective on shares of Aurora Cannabis from C$12.50 to C$11.00 and set a “sector perform” rating for the company in a report on Friday, June 21st.

Get Our Latest Analysis on Aurora Cannabis

Aurora Cannabis Trading Down 2.3 %

The company has a debt-to-equity ratio of 16.95, a quick ratio of 2.48 and a current ratio of 3.76. The firm has a market cap of C$414.87 million, a P/E ratio of -12.05 and a beta of 2.72. The firm has a 50 day simple moving average of C$8.29 and a 200 day simple moving average of C$8.01.

Aurora Cannabis (TSE:ACBGet Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported C($0.16) EPS for the quarter, beating analysts’ consensus estimates of C($0.48) by C$0.32. The company had revenue of C$92.04 million during the quarter, compared to analyst estimates of C$76.70 million. Aurora Cannabis had a negative net margin of 11.53% and a negative return on equity of 6.13%. On average, equities research analysts predict that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.

Read More

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.